Gelstat Corp
GSAC- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000890725
No open-market purchases or sales by Gelstat Corp insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GSAC, Q2 2026
No superinvestor reported holding GSAC at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Gelstat Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 (view filing)11:47 AM ET | Feb 4 | 32 daysLate | Goldfarb Adrian GrahamDirector | PPurchaseCommon Stock, par value $0.01 | +87.1M | $0.0045 | +$390.9K | +12,168.5%87.8M after | 4 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Gelstat Corp at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding GSAC in 13F filings for Q2 2026.